Center for American Progress Center for American Progress
Issues Domestic Bioethics & Science

Too Much to Ask

The States Simply Cannot Make Up for Federal Inaction on Stem Cell Research

The latest outcome in the ongoing national debate about human embryonic stem cell research is unprecedented in the history of science funding in the United States. President Bush’s recent veto of the Stem Cell Research Enhancement Act means that a cutting edge field of scientific inquiry will soon receive its strongest support not from the federal government, but from the states.

Although Washington provides the majority of funding for stem cell research, it refuses to permit scientists to work with new and more effective lines of human embryonic stem cells. The states have moved to fill this gap in order to allow American scientists to use the best tools in the race for life-saving cures. Yet as important and admirable as these state initiatives are, they cannot replace the leadership that would be provided by the National Institutes of Health (NIH).

Nor is a decentralized research system as efficient as the federal structure that is already in place. The differing federal and state stem cell research policies have forced states to spend the bulk of their money on building infrastructure, purchasing equipment and training scientists, not on funding actual research projects. And contrary to the impression that funding by the states of this emerging field of science is substantial, our analysis demonstrates that allocated state funding—funding designated for specific purposes—is currently modest at best and not targeted towards research that is ineligible for federal funding.

States are supporting stem cell research to the best of their abilities, but only combining their efforts with stronger federal support will truly advance stem cell research. We need to pass the Stem Cell Research Enhancement Act and increase federal funding for embryonic stem cell research in order to remedy the situation and ensure the United States remains at the forefront of this major new scientific field — for the benefit of our science, our citizens, and our economy.

To speak with our experts on this topic, please contact:

Print: Suzi Emmerling (foreign policy and security, energy, education, immigration)
202.481.8224 or semmerling@americanprogress.org

Print: Jason Rahlan (health care, economy, civil rights, poverty)
202.481.8132 or jrahlan@americanprogress.org

Radio: John Neurohr
202.481.8182 or jneurohr@americanprogress.org

TV: Andrea Purse
202.741.6250 or apurse@americanprogress.org

Web: Erin Lindsay
202.741.6397 or elindsay@americanprogress.org

Subscribe to RSS Feeds

RSS IconSite-Wide and Issue-Specific RSS Feeds

Related Articles

Ask the Expert: Patching America's Leaky Pipeline in the Sciences, by Mary Ann Mason

Staying Competitive, by Marc Goulden, Karie Frasch, Mary Ann Mason

New Tools for Old Traumas, by Sarah Dreier, William F. Schulz

Ask the Expert: The Right Treatment for the Right Patient, by Michael Rugnetta

Innovation Clusters Create Competitive Communities, by Jonathan Sallet, Ed Paisley

Also by Jonathan D. Moreno

Collins for Health, July 10, 2009

Back to the Future, July 6, 2009

Comparative Effectiveness Research Will Help People Make Better Health Choices, May 1, 2009

Also by Sam Berger

A Challenge to Progressives on Choice, July 18, 2007

Keeping the Doctor Away: Ideology Is This Administration’s Prescription, July 11, 2007

Estranged Bedfellows, June 25, 2007

Also by Alix Rogers

Divided We Fail: The Need for National Stem Cell Funding, April 12, 2007